HRT

Hormone replacement therapy is the treatment of choice for climacteric symptoms of women in different stages of the menopause. Nowadays, women suffering from climacteric symptoms – whether physiological or psychological – have a choice of well-tolerated, safe and efficacious low-dose hormone replacement preparations.

Experts recommend that HRT be started early with a low-dose sequential combined formulation in order to alleviate symptoms and to maintain a regular cycle. A complete stop of monthly bleedings can be achieved by switching earlier to a continuous combined low-dose product which also improves the quality of life. This is of particular importance for women in the 21st century who have an extended life expectancy and expect to live a fulfilled life also in their later years.

Since the publication of the results of the Women’s Health Initiative Study (WHI), which was prematurely discontinued due to an unfavorable risk/benefit ratio, it has become quite clear that not all compounds are the same and that low-dose preparations are the future of HRT.

Novo Nordisk offers a low-dose range with compounds, combinations and products for safe and efficacious treatment of climacteric symptoms – the right product for every individual need.